Biotron Limited Is A Clinical Stage Biotechnology Company Based In North Rydenew South Walesaustraliathe Company Specializes In Developing Antiviral Drugsfocusing On Small Molecule Therapeutics That Target Viroporinsae Proteins Essential For Viral Replicationbiotron Is Dedicated To Addressing Viral Infections Such As Hiv 1Hepatitis Cand Sars Cov 2 Through Innovative Mechanisms That Disrupt Viral Lifecycle Processes The Lead Compoundbit225Is Currently In Phase 2 Trials For Hiv 1 And Hepatitis Caiming To Target Viral Reservoirs In Macrophage Cellsadditionallybit225 Has Shown Preclinical Efficacy Against Sars Cov 2Leading To An Accelerated Clinical Development Programbiotron Also Has A Preclinical Pipeline That Includes Candidates For Hepatitis Bdenguezikainfluenzaand Ebolaall Utilizing The Viroporin Targeting Approachthe Company Is Publicly Traded On The Australian Securities Exchange And Focuses On Drug Discovery And Clinical Developmentcollaborating With Healthcare Partners And Regulatory Bodies To Advance Its Compounds
